Table 3.
Univariate analysis for overall survival.
| Covariate | Level | N | Hazard Ratio (95% CI) | HR p value | Log-rank p value |
|---|---|---|---|---|---|
| Bacteremia | Yes | 36 | 3.32 (1.53–7.19) | .002 | .001 |
| No | 142 | - | - | ||
| Diagnosis | MF | 133 | 0.92 (0.27–3.15) | .900 | .047 |
| SS | 18 | 3.04 (0.72–12.77) | .129 | ||
| Other | 27 | - | - | ||
| Stage (early/late) | 2B-4 | 86 | 4.01 (1.65–9.75) | .002 | .001 |
| 1–2A | 80 | - | - | ||
| Race | Black | 87 | 0.51 (0.23–1.12) | .093 | .087 |
| White/Hispanic | 91 | - | - | ||
| Sex | Male | 93 | 1.22 (0.56–2.65) | .611 | .610 |
| Female | 85 | - | - | ||
| Age at diagnosis | ≥65 | 51 | 3.66 (1.65–8.13) | .001 | <.001 |
| <65 | 127 | - | - | ||
| Outpatient dermatology consult | Yes | 112 | 0.96 (0.35–2.66) | .944 | .945 |
| No | 40 | - | - |